Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
Advances in Radiation Oncology
|
July 31, 2019
Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
Michelle Guan, Ingrid He, Michael Luu, et al.
JCO Precision Oncology
|
August 20, 2025
Evaluating the Effect of <i>KRAS</i> Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer
Matthew I Ebia, Edik M Blais, Yujie Cui, et al.
Clinical and Molecular Hepatology
|
July 23, 2023
Recent advances in the management of hepatocellular carcinoma
Kamya Sankar, Jun Gong, Arsen Osipov, et al.
Human Pathology
|
December 13, 2025
Gastric neuroendocrine tumors associated with acid suppressant drugs are frequently associated with very prolonged drug use and may show unconventional morphologies
Mahzad Azimpouran, Kevin M Waters, Andrew E Hendifar, et al.
Pharmacogenetics and Genomics
|
November 7, 2008
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer
Georg Lurje, Andrew E Hendifar, Anne M Schultheis, et al.
NPJ Digital Medicine
|
July 16, 2019
Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients
Gillian Gresham, Andrew E Hendifar, Brennan Spiegel, et al.
Investigational New Drugs
|
October 20, 2022
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161
Lakshmi Rajdev, Ju-Whei Lee, Steven K Libutti, et al.
Journal of the American College of Surgeons
|
February 5, 2026
Surgical and Oncologic Outcomes After Pancreatectomy for Pancreatic Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 and von Hippel-Lindau Syndrome: A Large, Multi-Institutional, Cohort Study
Liti Zhang, Marco Ventin, Shahrzad Arya, et al.
Contemporary Clinical Trials
|
November 14, 2017
Wearable activity monitors in oncology trials: Current use of an emerging technology
Gillian Gresham, Jennifer Schrack, Louise M Gresham, et al.
Plos One
|
June 26, 2019
Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data
Aileen Baecker, Sungjin Kim, Harvey A Risch, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
Advances in Radiation Oncology
|
July 31, 2019
Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
Michelle Guan, Ingrid He, Michael Luu, et al.
JCO Precision Oncology
|
August 20, 2025
Evaluating the Effect of <i>KRAS</i> Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer
Matthew I Ebia, Edik M Blais, Yujie Cui, et al.
Clinical and Molecular Hepatology
|
July 23, 2023
Recent advances in the management of hepatocellular carcinoma
Kamya Sankar, Jun Gong, Arsen Osipov, et al.
Human Pathology
|
December 13, 2025
Gastric neuroendocrine tumors associated with acid suppressant drugs are frequently associated with very prolonged drug use and may show unconventional morphologies
Mahzad Azimpouran, Kevin M Waters, Andrew E Hendifar, et al.
Pharmacogenetics and Genomics
|
November 7, 2008
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer
Georg Lurje, Andrew E Hendifar, Anne M Schultheis, et al.
NPJ Digital Medicine
|
July 16, 2019
Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients
Gillian Gresham, Andrew E Hendifar, Brennan Spiegel, et al.
Investigational New Drugs
|
October 20, 2022
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161
Lakshmi Rajdev, Ju-Whei Lee, Steven K Libutti, et al.
Journal of the American College of Surgeons
|
February 5, 2026
Surgical and Oncologic Outcomes After Pancreatectomy for Pancreatic Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 and von Hippel-Lindau Syndrome: A Large, Multi-Institutional, Cohort Study
Liti Zhang, Marco Ventin, Shahrzad Arya, et al.
Contemporary Clinical Trials
|
November 14, 2017
Wearable activity monitors in oncology trials: Current use of an emerging technology
Gillian Gresham, Jennifer Schrack, Louise M Gresham, et al.
Plos One
|
June 26, 2019
Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data
Aileen Baecker, Sungjin Kim, Harvey A Risch, et al.
Page
of 9